20th Sep 2011 07:00
Verona Pharma plc ("Verona Pharma" or the "Company") Exercise of Options
20 September 2011 - London, UK - The Company today announces that options to subscribe for 2,277,570 ordinary shares of 0.1 pence in the Company (the " Ordinary Shares") were exercised on 16 September 2011 (the "Options"). 1,000,000 of the Options had an exercise price of 5 pence and 1,277,570 of the Options had an exercise price of 6 pence.
The new Ordinary Shares will rank pari passu with the existing Ordinary Shares in the Company. Application has been made for the new Ordinary Shares to be admitted to trading on the AIM market of the London Stock Exchange ("Admission"). It is expected that Admission will become effective on 23 September 2011.
Following Admission, the Company will have 242,184,275 Ordinary Shares in issue. The new Ordinary Shares will represent approximately 0.94 per cent. of the issued share capital of the Company immediately following Admission.
For more information please contact:
Verona Pharma plc Tel: 020 7863 3300 Clive Page, Chairman [email protected] Michael Walker, CEO Evolution Securities Limited Tel: 020 7071 4300(NOMAD and Joint Broker) [email protected] Andrews / James Nevin / Patrick Castle
WH Ireland Group Plc (Joint Broker) Tel: 0121 265 6300 Richard Smith / Jessica Metcalf
[email protected] College Hill Tel: 020 7457 2020Melanie Toyne Sewell / Gemma Howe [email protected]
XLONRelated Shares:
VRP.L